Lymphedema Diagnostics Market Expected to Flourish and Reaching USD 70.7 million by 2034 | States Transparency Market Research, Inc.


The rising incidence of chronic diseases like lymphedema is significantly driving the growth of the lymphedema diagnostics market.

Wilmington, Delaware, United States, Transparency Market Research. Inc., July 09, 2024 (GLOBE NEWSWIRE) — The global lymphedema diagnostics market (림프부종 진단 시장) stood at US$ 41.9 million in 2023, and the global market is projected to reach US$ 70.7 million in 2034. The lymphedema diagnostics market is anticipated to expand at a CAGR of 4.8% between 2024 and 2034.

The lymphedema diagnostics market is experiencing significant growth, driven by the rising prevalence of chronic diseases such as lymphedema. Lymphedema, characterized by the abnormal accumulation of lymph fluid, often leads to swelling in the arms or legs and can result from conditions like cancer or infections.


As awareness of this condition increases, the demand for accurate and early diagnostic tools is surging. Technological advancements are at the forefront of this market expansion, with innovations aimed at improving the accuracy, efficiency, and accessibility of diagnostic procedures.

One of the key drivers of this market is the incorporation of advanced imaging techniques such as lymphoscintigraphy, MRI, and ultrasound. These technologies offer precise imaging of the lymphatic system, allowing for early detection and intervention.

Additionally, portable diagnostic devices are gaining popularity, providing convenient and timely diagnostics in various healthcare settings. The integration of artificial intelligence and machine learning in diagnostic tools is also revolutionizing the market by enabling faster and more accurate interpretations of imaging results.

Request for sample PDF copy of report:

The increasing focus on personalized medicine is further propelling the lymphedema diagnostics market. Personalized approaches consider individual patient characteristics, leading to tailored diagnostic and treatment plans. This trend is supported by advancements in genetic testing and biomarkers, which help identify patients at higher risk and monitor disease progression more effectively.

The growing geriatric population, which is more susceptible to chronic conditions, is boosting the demand for lymphedema diagnostics. Governments and healthcare organizations are also playing a crucial role by investing in awareness programs and subsidizing diagnostic procedures, making them more accessible to a broader population.

Key Takeaways of Market Report

  • Global lymphedema diagnostics market to generate absolute dollar opportunity worth US$ 70.7 million until 2034.
  • Global lymphedema diagnostics market is valued at US$ 41.9 million in 2023.
  • North America is forecasted to hold the largest share in 2023.

Lymphedema Diagnostics Market: Growth Drivers Top of Form

  • Lymphedema is a chronic condition characterized by the accumulation of excess fluid in the body’s tissues, leading to swelling. It often arises due to genetic mutations affecting the lymphatic system, and can also result from inflammatory conditions or radiation therapy. The increasing incidence of lymphedema has spurred significant interest in developing advanced diagnostic modalities to enhance early detection and treatment.
  • Key players in the lymphedema diagnostics market are heavily investing in innovative diagnostic technologies to expand their market share. Among these, ImpediMed, a medical technology company based in Australia with operations in Europe and the United States, stands out.
  • ImpediMed is known for its cutting-edge diagnostic tools designed to improve the accuracy and efficiency of lymphedema detection. By focusing on technological advancements and global expansion, companies like ImpediMed are driving growth in the lymphedema diagnostics market, ultimately aiming to improve patient outcomes through earlier and more reliable diagnostics.

Unlock Growth Potential in Your Industry! Download PDF Brochure:

Lymphedema Diagnostics Market: Regional Landscape

  • North America held the largest share of the lymphedema diagnostic imaging market, a dominance expected to continue throughout the forecast period.
  • This leadership is attributed to the growing incidence of chronic diseases and the rising awareness of the benefits of early lymphedema diagnosis. The region’s advanced healthcare infrastructure and increased investment in diagnostic technologies also contribute to its significant market share.
  • The Asia Pacific region is witnessing noticeable growth in the lymphedema diagnostics market (リンパ浮腫画像診断市場), driven by a heightened awareness of real-time lymphedema diagnosis among the populace.
  • Countries such as India and China are at the forefront of this growth, with numerous R&D activities focused on developing advanced diagnostic procedures. This regional expansion is further supported by improving healthcare systems and increased government initiatives to promote early diagnosis and effective management of lymphedema.Top of FormBottom of Form

Lymphedema Diagnostics Market: Key Players

  • In 2023, GE HealthCare introduced an advanced ultrasound system specifically designed for lymphedema diagnostics. This system integrates high-resolution imaging with AI-powered analytics to enhance the accuracy and speed of detecting lymphatic abnormalities. The innovation aims to facilitate earlier and more precise diagnosis, improving treatment outcomes for lymphedema patients.
  • In 2023, Koninklijke Philips N.V. launched a novel imaging platform that combines magnetic resonance imaging (MRI) with sophisticated software algorithms tailored for lymphedema diagnostics. This platform offers detailed visualization of the lymphatic system, enabling healthcare professionals to identify and assess lymphedema more effectively.
  • The development underscores Philips’ commitment to leveraging cutting-edge technology to advance diagnostic capabilities and patient care in the field of lymphedema.

Lymphedema Diagnostics Market: Segmentation


  • Lymphoscintigraphy
  • Near-Infrared Fluorescence Imaging
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound Imaging
  • Computed Tomography (CT)
  • Others


  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes


  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Buy this Premium Research Report:

More Trending Reports by Transparency Market Research –

Consumer Genomics MarketThe global consumer genomics market (Markt für Verbrauchergenomik) was estimated to have acquired US$ 2.4 billion in 2021. It is anticipated to register a 22.3% CAGR from 2022 to 2032 and by 2032, the market is likely to gain US$ 21.2 billion.

Acute Migraine Treatment MarketThe global market for acute migraine treatment (traitement de la migraine aiguë) was estimated to be worth a market valuation of around US$ 2.1 billion in 2021. The market is anticipated to advance with a booming 15.1% CAGR from 2023 to 2031 and by 2031, the market is likely to gain US$ 7.9 billion.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research Inc.


1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453


Email: [email protected]

Follow Us: LinkedIn| Twitter| Blog | YouTube

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.